Safety and Efficacy of Cryoablation for Abdominal Pain Associated With Pancreatic Cancer

Stopped early · Phase 1

Conditions studied: Pain, Pancreatic Cancer

In brief

CUC10-PAN09 will evaluate the safety and efficacy of cryoablation therapy on the relief of epigastric/abdominal pain associated with pancreatic cancer.

Key facts

Study ID

NCT01335945

Run by

Boston Scientific Corporation

People needed

14

Starts

2011-08-01

Expected to finish

2015-01-01

Last updated by the study team

2021-07-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject must be at least 18 years old
• Subject has unresectable or inoperable pancreatic carcinoma as determined by CT or MRI
• Subject's epigastric/abdominal 'worst pain' in the last 24 hours must be reported to be 4 or above on a scale of 0 (no pain) to 10 (pain as bad as subject can imagine) on the BPI despite pharmaceutical pain management
• ECOG of 0-3
• Platelet count >50,000
• INR <1.5

You may not qualify if…

• Subject's life expectancy is <3 months
• Subject has current neutropenia (ANC <1000)
• Subject unable to undergo CT or MRI
• Subject had previous ETOH neurolytic block for pancreatic cancer-related pain less than 2 weeks from screening
• Subject had surgery <4 weeks from screening

Where it is running

• Karmanos Cancer Institute — Detroit, Michigan, United States
• The Research Foundation of State University New York — Stony Brook, New York, United States
• University Hospitals — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.